Geron (GERN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

GERN Geron

Watchlist

3.490
-0.170-4.64%

Close Dec 20 16:00 ET

3.510
+0.020+0.57%

Post 20:01 ET

2.11BMarket Cap-10.91P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BusinesswireDec 19 16:30 ET
Express News | Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersDec 19 16:30 ET
Geron Corporation (NASDAQ:GERN) Is a Favorite Amongst Institutional Investors Who Own 72%
Yahoo FinanceDec 18 13:19 ET
Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $6
Moomoo NewsDec 13 09:31 ET · Ratings
Sector Update: Health Care Stocks Steady Premarket Friday
MT NewswiresDec 13 09:17 ET
Express News | Needham Reiterates Buy on Geron, Maintains $6 Price Target
BenzingaDec 13 09:05 ET

Comments

Trytosaveabit

Dec 13 05:51

Update

$Geron (GERN.US)$ Geron Says Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Approval Of RYTELO (Imetelstat) For Treatment Of Adult Patients With Transfusion-dependent (TD) Anemia Due To Very Low, Low Or Intermediate Risk Myelodysplastic Syndromes
Company says Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of RYTELO (imetelstat) for the treat...

Trytosaveabit

Dec 10 08:03

Update

$Geron (GERN.US)$ Reuters
3 mins ago
Geron Announces Phase 1 Findings From Two-Part Improvemf Study Presented at Ash Suggesting Tolerability of Rytelo™ (Imetelstat) in Combination With Ruxolitinib as Frontline Therapy in Patients With Myelofibrosis

Tonyco

Nov 17 17:09

$Geron (GERN.US)$
Almost low enough

Trytosaveabit

Nov 7 06:27

A bit more

$Geron (GERN.US)$ Reuters· 2 mins ago
Geron Corp - Receives $250 Million at Closing, $125 Million in Debt Available

Trytosaveabit

Nov 7 06:13

News

$Geron (GERN.US)$ Reuters· 1 mins ago
Royalty Pharma to Acquire Royalty Interest in Geron’s Rytelo for $125 Million

Heat List

Overall

No Data